Mostrar el registro sencillo del ítem

Usefulness of the USG Doppler evaluation of the uterine arteries between weeks 11 and 13+6 and its application in risk calculators to predict preeclampsia

Utilidad de la evaluación USG Doppler de las arterias uterinas entre las semanas 11 y 13+6 y su aplicación en las calculadoras de riesgo para predecir preeclampsia

dc.creatorOtero-Rosales, María Camila
dc.creatorOlarte-Marín, Cristhian David
dc.creatorPadilla-Serpa, Johan Danilo
dc.creatorMorales-Duarte, Paula Andrea
dc.creatorQuintero-Roa, Eliana Maribel
dc.date2022-01-05
dc.date.accessioned2022-03-03T21:03:17Z
dc.date.available2022-03-03T21:03:17Z
dc.identifierhttps://revistas.unab.edu.co/index.php/medunab/article/view/3953
dc.identifier10.29375/01237047.3953
dc.identifier.urihttp://test.repositoriodigital.com:8080/handle/123456789/16519
dc.descriptionIntroduction. Preeclampsia is the primary cause of direct maternal death in Colombia and the second globally. The development of prediction and prevention strategies can reduce complications and consequences caused by this disease. The uterine arteries Doppler between weeks 11 and 13+6 as an independent test or in combination with maternal factors or biochemical tests allows for early detection rates for preeclampsia of ≥90% from the implementation of different sieving. The validity of this diagnostic test has a sensitivity of 47.8% and specificity of 92.1% for the early detection of preeclampsia; with a sensitivity of 26.4% and specificity of 93.4% to predict preeclampsia at any stage. Division of Covered Topics. This topic review covers the usefulness of this measurement. It discusses the performance of the technique in question and, lastly, the standardized tools currently available are reviewed together with the accessibility and accuracy. Conclusions. The empirical evidence that supports the validity of the tools available today for the screening of preeclampsia via Doppler ultrasound evaluation of the uterine arteries is significant. As Colombia is a country with a high prevalence of preeclampsia, knowing the usefulness of this measurement favors early and timely surveillance, which reduces possible unfavorable outcomes for mothers.en-US
dc.descriptionIntroducción. La preeclampsia es la primera causa de muerte materna directa en Colombia y la segunda a nivel mundial. El desarrollo de estrategias de predicción y prevención puede disminuir las complicaciones y secuelas ocasionadas por dicha enfermedad. El Doppler de arterias uterinas entre las semanas 11 y 13+6 como prueba independiente o en combinación con factores maternos o pruebas bioquímicas permite tasas de detección de preeclampsia temprana ≥ 90% a partir de la implementación de distintos cribados. La validez de dicha prueba diagnóstica presenta una sensibilidad del 47.8% y especificidad del 92.1% para la detección de preeclampsia temprana; con una sensibilidad del 26.4% y especificidad del 93.4% para predecir preeclampsia en cualquier etapa. División de los temas tratados. En esta revisión de tema se aborda la utilidad de esta medición, se habla de la realización de la técnica en cuestión y, por último, se revisan las herramientas estandarizadas que están disponibles en la actualidad junto con su accesibilidad y precisión. Conclusiones. La evidencia empírica que respalda la validez de las herramientas disponibles hoy en día para el tamizaje de preeclampsia a través de la evaluación por ultrasonografía Doppler de las arterias uterinas es significativa. Al ser Colombia un país que presenta una prevalencia alta de preeclampsia, conocer la utilidad de esta medición favorece una vigilancia temprana y oportuna, lo que disminuye los posibles desenlaces desfavorables para las maternas.es-ES
dc.formatapplication/pdf
dc.formattext/xml
dc.languagespa
dc.publisherUNABes-ES
dc.relationhttps://revistas.unab.edu.co/index.php/medunab/article/view/3953/3546
dc.relationhttps://revistas.unab.edu.co/index.php/medunab/article/view/3953/3560
dc.relation/*ref*/Lakshmy S, Ziyaulla T, Rose N. The need for implementation of first trimester screening for preeclampsia and fetal growth restriction in low resource settings. J Matern-Fetal Neo M [Internet]. 2020;34(24):4082-9. doi: https://doi.org/10.1080/14767058.2019.1704246 2. Instituto Nacional de Salud; Boletín Epidemiológico Semanal [Internet]. Semana Epidemiológica 23.. 2019. Recuperado a partir de: https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2019%20Bolet%C3%ADn%20epidemiol%C3%B3gico%20semana%2023.pdf 3. El-Sayed AAF. Preeclampsia: A review of the pathogenesis and possible management strategies based on its pathophysiological derangements. Taiwan J Obstet Gynecol [Internet]. 2017;56(5):593-8. doi: https://doi.org/10.1016/j.tjog.2017.08.004 4. Sotiriadis A, Hernandez‐Andrade E, da Silva Costa F, Ghi T, Glanc P, Khalil A, et al. ISUOG Practice Guidelines: Role of ultrasound in screening for and follow‐up of pre‐eclampsia. Ultrasound Obstet Gynecol. [Internet]. 2019;53(1):7-22. doi: https://doi.org/10.1002/uog.20105 5. Campbell S, Griffin DR, Pearce JM, Diaz-Recasens J, Cohen-Overbeek TE, Willson K, et al. New doppler technique for assessing uteroplacental blood flow. Lancet [Internet]. 1983;321(8326):675-677. doi: https://doi.org/10.1016/s0140-6736(83)91970-0 6. Acolet D, Springett A, Golightly S. Perinatal Mortality 2006 [Internet]. Confidential Enquiry into Maternal and Child Health; 2008. Recuperado a partir de: https://www.oaa-anaes.ac.uk/assets/_managed/editor/File/Reports/2006_Perinatal_mortality.pdf 7. Farré MT, Borrell A, Ravenau W, Azulay M, Cararach V, Fortuny A. Estudio Doppler de las arterias uterinas: predicción de complicaciones perinatales. Prog Obstet Ginecol [Internet]. 2001;44(12):537-43. doi: https://doi.org/10.1016/S0304-5013(01)75714-7 8. Papageorghiou A, Yu CKH, Bindra R, Pandis G, Nicolaides KH. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol. 2001;18(5):441-9. doi: https://doi.org/10.1046/j.0960-7692.2001.00572.x 9. Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol [Internet]. 2001;18(6):583-6. doi: https://doi.org/10.1046/j.0960-7692.2001.00594.x 10. Velauthar L, Plana MN, Kalidindi M, Zamora J, Thilaganathan B, Illanes SE, et al. First‐trimester uterine artery Doppler and adverse pregnancy outcome: A meta‐analysis involving 55 974 women. Ultrasound Obstet Gynecol [Internet]. 2014;43(5): 500-7. doi: https://doi.org/10.1002/uog.13275 11. von Dadelszen P, Payne B, Li J, Ansermino JM, Pipkin F, Côté AM, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet [Internet]. 2011;377(9761):219-27. doi: https://doi.org/10.1016/S0140-6736(10)61351-7 12. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol [Internet]. 2014;10:466-80. doi: https://doi.org/10.1038/nrneph.2014.102 13. Orabona R, Donzelli C, Falchetti M, Santoro A, Valcamonico A, Frusca T. Placental histological patterns and uterine artery Doppler velocimetry in pregnancies complicated by early or late pre-eclampsia. Ultrasound Obstet Gynecol [Internet]. 2016;47(5):580-5. doi: https://doi.org/10.1002/uog.15799 14. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of Preeclampsia and Intrauterine Growth Restriction with Aspirin Started in Early Pregnancy: A Meta-Analysis. Obstet Gynecol [Internet]. 2010;116(2p1):402-14. doi: https://doi.org/10.1097/aog.0b013e3181e9322a 15. Dugoff L, Lynch AM, Cioffi-Ragan D, Hobbins JC, Schultz LK, Malone FD, et al. First trimester uterine artery Doppler abnormalities predict subsequent intrauterine growth restriction. Am J Obstet [Internet]. 2005;193(3):1208-12. doi: https://doi.org/10.1016/j.ajog.2005.06.054 16. Plasencia W, Barber M, Álvarez E, Segura J, Valle L, Garcia-Hernandez J. Comparative Study of Transabdominal and Transvaginal Uterine Artery Doppler Pulsatility Indices at 11-13 + 6 Weeks. Hypertens Pregnancy. 2011;30(4):414-20. doi: https://doi.org/10.3109/10641955.2010.506232 17. Cortés-Yepes H. Doppler de arterias uterinas en el primer trimestre del embarazo para la detección de los trastornos hipertensivos asociados con el embarazo: estudio de cohorte. Bogotá (Colombia) 2007-2008. Rev Colomb Obstet Ginecol. [Internet]. 2009;60(4):328-33. doi: https://doi.org/10.18597/rcog.315 18. Khalil A, Nicolaides KH. How to record uterine artery Doppler in the first trimester. Ultrasound Obstet Gynecol [Internet]. 2013;42:478-9. doi: https://doi.org/10.1002/uog.12366 19. Witlin AG, Saade GR, Mattar F, Sibai BM. Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24 and 33 weeks' gestation. Am J Obstet [Internet]. 2000;182(3):607-11. doi: https://doi.org/10.1067/mob.2000.104224 20. Demers ME, Dubé S, Bourdages M, Gasse C, Boutin A, Girard M et al. Comparative Study of Abdominal Versus Transvaginal Ultrasound for Uterine Artery Doppler Velocimetry at 11 to 13 Weeks. J Ultrasound Med [Internet]. 2018;37(7):1771-6. doi: https://doi.org/10.1002/jum.14530 21. Tayyar A, Guerra L, Wright A, Wright D, Nicolaides KH. Uterine artery pulsatility index in the three trimesters of pregnancy: Effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol [Internet]. 2015;45(6):689-97. doi: https://doi.org/10.1002/uog.14789 22. Rivas M, González X, Guevara H. Valores de referencia del índice de pulsatilidad de la arteria uterina durante el embarazo. Rev Obstet Ginecol Venez [Internet]. 2016;76(3):225-31. Recuperado a partir de: http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S0048-77322016000400002&lng=es 23. Ferreira AEGMT, Mauad Filho F, Abreu PSG, Mauad FM, Araujo Júnior E, Martins WP. Reproducibility of first- and second-trimester uterine artery pulsatility index measured by transvaginal and transabdominal ultrasound. Ultrasound Obstet Gynecol [Internet]. 2015;46(5):546-52. doi: https://doi.org/10.1002/uog.14762 24. Peixoto A, Rodrigues Da Cunha Caldas T, Tonni G, Almeida Morelli P, Santos L, Martins W, et al. Reference range for uterine artery Doppler pulsatility index using transvaginal ultrasound at 20-24w6d of gestation in a low-risk Brazilian population. J Turk Ger Gynecol Assoc. 2016;17:16-20. doi: https://doi.org/10.5152/jtgga.2016.16192 25. Gómez O, Martínez JM, Figueras F, Del Río M, Borobio V, Puerto B, et al. Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population. Ultrasound Obstet Gynecol [Internet]. 2005;26(5):490-4. doi: https://doi.org/10.1002/uog.1976 26. Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and prevention. Int J Gynecol Obstet [Internet]. 2019;145(S1):1-33. doi: https://doi.org/10.1002/ijgo.12802 27. O’Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol [Internet]. 2016;214(1):103.e1-12. doi: https://doi.org/10.1016/j.ajog.2015.08.034 28. O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, et al. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol [Internet]. 2017;49(6):751-755. doi: https://doi.org/10.1002/uog.17399 29. O'Gorman N, Wright D, Poon L, Rolnik D, Syngelaki A, de Alvarado M, et al. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: Comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol [Internet]. 2017;49(6):756-60. doi: https://doi.org/10.1002/uog.17455 30. ACOG. First-Trimester Risk Assessment for Early-Onset Preeclampsia. Committee opinion No. 638. Obstet Gynecol. 2015;126:e25-7. doi: https://doi.org/10.1097/aog.0000000000001049 31. National Collaborating Centre for Women's and Children's Health (UK). Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. London: RCOG Press; 2010 Aug. (NICE Clinical Guidelines, No. 107.) Recuperado a partir de: https://www.ncbi.nlm.nih.gov/books/NBK62652/ 32. Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides K. Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers. Fetal Diagn Ther. 2013;33(1):8-15. doi: https://doi.org/10.1159/000341264 33. Rolnik DL, Wright D, Poon LCY, Syngelaki A, O'Gorman N, de Paco Matallana C, et al. ASPRE trial: Performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol [Internet]. 2017;50(4):492-5. doi: https://doi.org/10.1002/uog.18816 34. Skråstad R, Hov G, Blaas H, Romundstad P, Salvesen K. Risk assessment for preeclampsia in nulliparous women at 11-13 weeks gestational age: Prospective evaluation of two algorithms. BJOG [Internet]. 2015;122(13):1781-8. doi: https://doi.org/10.1111/1471-0528.13194 35. Lakovschek IC, Ulrich D, Jauk S, Csapo B, Kolovetsiou-Kreiner V, Mayer-Pickel K, et al. Risk assessment for preterm preeclampsia in first trimester: Comparison of three calculation algorithms. Eur J Obstet Gynecol [Internet]. 2018;231:241-7. doi: https://doi.org/10.1016/j.ejogrb.2018.11.006 36. Duley L. The Global Impact of Pre-eclampsia and Eclampsia. Semin Perinatol [Internet]. 2009;33(3):130-7. doi: https://doi.org/10.1053/j.semperi.2009.02.010 37. O'Gorman N, Nicolaides K, Poon L. The Use of Ultrasound and other Markers for Early Detection of Preeclampsia. Womens Health. 2016;12(2):199-207. doi: https://doi.org/10.2217/whe.15.95 38. Wright A, Wright D, Syngelaki A, Georgantis A, Nicolaides KH. Two-stage screening for preterm preeclampsia at 11-13 weeks’ gestation. Am J Obstet Gynecol [Internet]. 2019;220(2):197.e1-11. doi: https://doi.org/10.1016/j.ajog.2018.10.092 39. Tan MY, Syngelaki A, Poon LC, Rolnik DL, O'Gorman N, Delgado JL, et al. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol [Internet]. 2018;52(2):186-195. doi: https://doi.org/10.1002/uog.19112 40. Ridding G, Schluter PJ, Hyett JA, McLennan AC. Uterine Artery Pulsatility Index Assessment at 11-13 Weeks' Gestation. Fetal Diagn Ther [Internet]. 2014;36:299-304. doi: https://doi.org/10.1159/000361021
dc.rightsDerechos de autor 2021 MedUNABes-ES
dc.rightshttps://creativecommons.org/licenses/by-nc/4.0es-ES
dc.sourceMedUNAB; Vol. 24 No. 3 (2021): December 2021 - March 2022: COVID-19, Embolism and Thrombosis, Neoplasms; 375-383en-US
dc.sourceMedUNAB; Vol. 24 Núm. 3 (2021): diciembre 2021 - marzo 2022: COVID-19, Embolia y Trombosis, Neoplasias; 375-383es-ES
dc.source2382-4603
dc.source0123-7047
dc.subjectPre-Eclampsiaen-US
dc.subjectUltrasonographyen-US
dc.subjectUltrasonography; Prenatalen-US
dc.subjectUterine Arteryen-US
dc.subjectPrenatal Careen-US
dc.subjectPrenatal Diagnosisen-US
dc.subjectFetal Growth Retardationen-US
dc.subjectNoninvasive Prenatal Testingen-US
dc.subjectPreeclampsiaes-ES
dc.subjectUltrasonografíaes-ES
dc.subjectUltrasonografía Prenatales-ES
dc.subjectArteria Uterinaes-ES
dc.subjectAtención Prenatales-ES
dc.subjectDiagnóstico Prenatales-ES
dc.subjectRetardo del Crecimiento Fetales-ES
dc.subjectPruebas Prenatales no Invasivases-ES
dc.titleUsefulness of the USG Doppler evaluation of the uterine arteries between weeks 11 and 13+6 and its application in risk calculators to predict preeclampsiaen-US
dc.titleUtilidad de la evaluación USG Doppler de las arterias uterinas entre las semanas 11 y 13+6 y su aplicación en las calculadoras de riesgo para predecir preeclampsiaes-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem